Skip to main content
. 2023 Mar 2;89:104475. doi: 10.1016/j.ebiom.2023.104475

Fig. 8.

Fig. 8

Cross-group analysis of neutralisation titres to the delta and omicron SARS-CoV-2 isolates. Neutralising titres to the delta (a) and omicron (b) isolates at the 1M post symptom onset (non-hospitalised COVID-19 [n = 6] and hospitalised COVID-19 groups [n = 6]) and 1M post vaccination (mRNA–mRNA [n = 9] and vector-mRNA groups [n = 5]). Neutralising titres to the delta (c) and omicron (d) isolates at the 1M post vaccination (non-hospitalised [n = 8] and hospitalised groups [n = 7]) and 1M post mRNA booster (triple vacc) and post infection (triple vacc + infection) (mRNA–mRNA [n = 6 and n = 9, respectively] and vector-mRNA groups [n = 5 and n = 8, respectively]) (right) time points. Statistical significance was determined by the Kruskal–Wallis test and corrected for multiple comparisons using Dunn's test. (∗∗p < 0.01, ∗∗∗p < 0.001 and ∗∗∗∗p < 0.0001).